Investigating the Risk Factors Associated With Acute Neurologic Dysfunction in Pediatric Hyperglycemic Emergencies on

Grant Scollay1, Zach Cantor2, Douglas D Fraser

  • 1From the Ornge, Mississauga, Ontario.

Pediatric Emergency Care
|October 30, 2024
PubMed

Insights

Pediatric patients experiencing hyperglycemic emergencies during transport are at risk for neurologic dysfunction. Younger age, severe acidosis, and higher creatinine are key risk factors identified in this study.

Area of Science:

  • Pediatric Critical Care
  • Emergency Medicine
  • Metabolic Disorders

Background:

  • Hyperglycemic emergencies pose significant risks to pediatric patients.
  • Acute neurologic dysfunction during transport can complicate patient management and outcomes.

Purpose of the Study:

  • To identify key characteristics of hyperglycemic emergencies in pediatric patients.
  • To determine risk factors for acute neurologic dysfunction during interfacility transport.

Main Methods:

  • Retrospective chart review of pediatric patients during interfacility transport (2009-2019).
  • Analysis of demographic, clinical, and transport variables.
  • Logistic regression models to assess predictors of neurologic dysfunction (Glasgow Coma Scale <14).

Main Results:

  • 24% of patients experienced neurologic dysfunction (GCS <14).
  • Neurologic dysfunction was associated with more severe acidosis (pH <7.10) and higher creatinine levels.
  • Younger age, severe acidosis, and elevated corrected sodium for glucose were identified as independent risk factors.

Conclusions:

  • Younger age, severe acidosis, and elevated corrected sodium for glucose are associated with acute neurologic dysfunction in pediatric hyperglycemic emergencies during transport.
  • Targeted interventions and adherence to clinical guidelines are recommended.
  • Further research into transport-related neurologic complications is warranted.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
153
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
874
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
511
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K